Sward Formulations Private Limited
About Sward Formulations Private Limited
Data last updated:
Sward Formulations Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2018PTC315055. Its GSTIN is 08ABACS8866Q1ZB (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kewal Chand Dakalia and Dinesh Dakalia.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No. C – 301 Plot No. 46 Sector 30 – A Vashi, Navi Mumbai, Maharashtra, India – 400705.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.19 Lakh. For the same year it recorded a net loss of ₹38,817 (net margin -32.5%) and EBITDA of ₹1.05 Lakh (EBITDA margin 88.3%). Revenue has grown at a compounded annual rate (CAGR) of 74% over three years and 33% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No. C – 301 Plot No. 46 Sector 30 – A Vashi, Navi Mumbai, Maharashtra, India – 400705
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Sward Formulations Private Limited FY 2024 filings available
Sward Formulations Private Limited reported revenue of ₹1.19 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR) of Sward Formulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years. EBITDA rose 546% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sward Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.05 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹38,817 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sward Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 88.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -32.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sward Formulations are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sward Formulations Private Limited
Sward Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Confervo Formulations Private Limited | ₹1.21 Lakh (FY 2021) | •••• | •••• | -91.0% | •••• | Chennai, Tamil Nadu, India |
| Salvavidas Industries Private Limited | ₹1.21 Lakh (FY 2025) | •••• | •••• | •••• | Surat, Gujarat, India | |
| Tulips Medicaments Pvt Ltd | ₹1.2 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Novello Medica Private Limited | ₹1.2 Lakh (FY 2025) | •••• | •••• | •••• | Dehradun, Uttarakhand, India | |
| Rouland Oxides Private Limited | ₹1.2 Lakh (FY 2024) | •••• | •••• | •••• | Telangana, India | |
| Sward Formulations Private Limited this company | ₹1.19 Lakh (FY 2024) | •••• | •••• | •••• | Navi Mumbai, Maharashtra, India | |
| Zyden Gentec Limited | ₹1.18 Lakh (FY 2020) | •••• | •••• | -99.0% | •••• | Kota, Rajasthan, India |
| Medhexia Pharmaceuticals Private Limited | ₹1.17 Lakh (FY 2021) | •••• | •••• | 2.0% | •••• | Gurgaon, Haryana, India |
| Pass (India) Private Limited | ₹1.17 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Uttar Pradesh, India |
| Rynish Pharmaceuticals Private Limited | ₹1.17 Lakh (FY 2025) | •••• | •••• | -98.0% | •••• | Mumbai, Maharashtra, India |
| Health Pharmacy Private Limited | ₹1.16 Lakh (FY 2025) | •••• | •••• | 187.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Sward Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Sward Formulations Private Limited
Sward Formulations has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kewal Chand Dakalia Also directs: Navmantra Agro Products Private Limited, Lucid Pharma Private Limited, Dhanlaxmi Realmart Private Limited and 2 more | Director | 26 Apr 2021 | 5 Years 5 Months | Current |
| Dinesh Dakalia Also directs: Navmantra Agro Products Private Limited, Navnidhi Super Infracon Private Limited, Sagorika Udyog Private Limited and 1 more | Director | 29 Sep 2018 | 8 Years 0 Months | Current |
Ownership and Shareholding of Sward Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sward Formulations Private Limited
Sward Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Sward Formulations Private Limited
Employment history and EPFO contributions of people linked to Sward Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sward Formulations Private Limited
Sward Formulations Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Ram Veer Singh Rathore ceased to be Director on 12 May 2021.
Credit Ratings, Litigation & Regulatory Alerts for Sward Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sward Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sward Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sward Formulations Private Limited
Sward Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08ABACS8866Q1ZB | Rajasthan | Active | 09 Jan 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sward Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sward Formulations Private Limited
Sward Formulations is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 September 2018 (8+ years old) and is registered under CIN U24100MH2018PTC315055.
Sward Formulations reported revenue of ₹1.19 Lakh for FY 2024.
Sward Formulations has 2 current directors:
- Kewal Chand Dakalia - Director
- Dinesh Dakalia - Director
Sward Formulations reported a net loss of ₹38,817 (net margin -32.5%) and EBITDA of ₹1.05 Lakh (EBITDA margin 88.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sward Formulations is -74% over three years and 33% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sward Formulations is 08ABACS8866Q1ZB, registered in Rajasthan.
The CIN (Corporate Identification Number) of Sward Formulations is U24100MH2018PTC315055. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sward Formulations was incorporated on 29 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sward Formulations by revenue are Confervo Formulations Private Limited, Salvavidas Industries Private Limited, Tulips Medicaments Pvt Ltd, Novello Medica Private Limited, Rouland Oxides Private Limited and 5 more, all in the Pharma industry (Formulations).
Ram Veer Singh Rathore ceased to be Director on 12 May 2021. Kewal Chand Dakalia was appointed as Director on 26 Apr 2021. Dinesh Dakalia was appointed as Director on 29 Sep 2018.
The registered office of Sward Formulations is at Flat No. C – 301 Plot No. 46 Sector 30 – A Vashi, Navi Mumbai, Maharashtra, India – 400705.